Effects of arginine vasopressin on cerebral microvascular pressure

F. M. Faraci, William Mayhan, P. G. Schmid, D. D. Heistad

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The goal of this study was to examine effects of arginine vasopressin and angiotensin on cerebral microvascular pressure and segmental vascular resistance. We measured pressure (servo-null) in pial arteries that were ~ 200 μm in diameter and cerebral blood flow (microspheres) in anesthetized cats, and we calculated resistance of large and small cerebral vessels. Resistance of large arteries (> 200 μm diam) was ~ 45% of total cerebral vascular resistance under control conditions. Vasopressin (40 mU/kg iv) decreased resistance of large arteries by 22 ± 7%; increased pial artery pressure by 10 ± 2 mmHg when aortic pressure was maintained at control levels, and increased small vessel resistance by 27 ± 11%. This increase in small vessel resistance apparently was an autoregulatory response to the increase in pial pressure. Cerebral blood flow was not changed (38 ± 4 vs. 37 ± 3 ml · min-1 · 100 g-1). Intravenous infusion of angiotensin (2 μg · kg-1 · min-1) increased large artery resistance by 32 ± 6%, decreased pial artery pressure 6 ± 3 mmHg with aortic pressure maintained constant, and decreased cerebral blood flow by 12 ± 1%. Thus circulating vasopressin, at concentrations similar to those observed during hemorrhage, selectively dilates large cerebral arteries and increases microvascular pressure without changes in cerebral blood flow. In contrast to vasopressin, angiotensin selectively increases resistance of large cerebral arteries and decreases cerebral microvascular pressure. Thus vasopressin and angiotensin, at doses that have minimal effects on cerebral blood flow, may play an important role in regulation of cerebral microvascular pressure.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume255
Issue number1
StatePublished - Jan 1 1988

Fingerprint

Arginine Vasopressin
Cerebrovascular Circulation
Pressure
Arteries
Angiotensins
Vasopressins
Cerebral Arteries
Vascular Resistance
Arterial Pressure
Microspheres
Intravenous Infusions
Cats
Hemorrhage

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Effects of arginine vasopressin on cerebral microvascular pressure. / Faraci, F. M.; Mayhan, William; Schmid, P. G.; Heistad, D. D.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 255, No. 1, 01.01.1988.

Research output: Contribution to journalArticle

@article{0f3cbe0a364f4ed993f6d8ca035c1520,
title = "Effects of arginine vasopressin on cerebral microvascular pressure",
abstract = "The goal of this study was to examine effects of arginine vasopressin and angiotensin on cerebral microvascular pressure and segmental vascular resistance. We measured pressure (servo-null) in pial arteries that were ~ 200 μm in diameter and cerebral blood flow (microspheres) in anesthetized cats, and we calculated resistance of large and small cerebral vessels. Resistance of large arteries (> 200 μm diam) was ~ 45{\%} of total cerebral vascular resistance under control conditions. Vasopressin (40 mU/kg iv) decreased resistance of large arteries by 22 ± 7{\%}; increased pial artery pressure by 10 ± 2 mmHg when aortic pressure was maintained at control levels, and increased small vessel resistance by 27 ± 11{\%}. This increase in small vessel resistance apparently was an autoregulatory response to the increase in pial pressure. Cerebral blood flow was not changed (38 ± 4 vs. 37 ± 3 ml · min-1 · 100 g-1). Intravenous infusion of angiotensin (2 μg · kg-1 · min-1) increased large artery resistance by 32 ± 6{\%}, decreased pial artery pressure 6 ± 3 mmHg with aortic pressure maintained constant, and decreased cerebral blood flow by 12 ± 1{\%}. Thus circulating vasopressin, at concentrations similar to those observed during hemorrhage, selectively dilates large cerebral arteries and increases microvascular pressure without changes in cerebral blood flow. In contrast to vasopressin, angiotensin selectively increases resistance of large cerebral arteries and decreases cerebral microvascular pressure. Thus vasopressin and angiotensin, at doses that have minimal effects on cerebral blood flow, may play an important role in regulation of cerebral microvascular pressure.",
author = "Faraci, {F. M.} and William Mayhan and Schmid, {P. G.} and Heistad, {D. D.}",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "255",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Effects of arginine vasopressin on cerebral microvascular pressure

AU - Faraci, F. M.

AU - Mayhan, William

AU - Schmid, P. G.

AU - Heistad, D. D.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The goal of this study was to examine effects of arginine vasopressin and angiotensin on cerebral microvascular pressure and segmental vascular resistance. We measured pressure (servo-null) in pial arteries that were ~ 200 μm in diameter and cerebral blood flow (microspheres) in anesthetized cats, and we calculated resistance of large and small cerebral vessels. Resistance of large arteries (> 200 μm diam) was ~ 45% of total cerebral vascular resistance under control conditions. Vasopressin (40 mU/kg iv) decreased resistance of large arteries by 22 ± 7%; increased pial artery pressure by 10 ± 2 mmHg when aortic pressure was maintained at control levels, and increased small vessel resistance by 27 ± 11%. This increase in small vessel resistance apparently was an autoregulatory response to the increase in pial pressure. Cerebral blood flow was not changed (38 ± 4 vs. 37 ± 3 ml · min-1 · 100 g-1). Intravenous infusion of angiotensin (2 μg · kg-1 · min-1) increased large artery resistance by 32 ± 6%, decreased pial artery pressure 6 ± 3 mmHg with aortic pressure maintained constant, and decreased cerebral blood flow by 12 ± 1%. Thus circulating vasopressin, at concentrations similar to those observed during hemorrhage, selectively dilates large cerebral arteries and increases microvascular pressure without changes in cerebral blood flow. In contrast to vasopressin, angiotensin selectively increases resistance of large cerebral arteries and decreases cerebral microvascular pressure. Thus vasopressin and angiotensin, at doses that have minimal effects on cerebral blood flow, may play an important role in regulation of cerebral microvascular pressure.

AB - The goal of this study was to examine effects of arginine vasopressin and angiotensin on cerebral microvascular pressure and segmental vascular resistance. We measured pressure (servo-null) in pial arteries that were ~ 200 μm in diameter and cerebral blood flow (microspheres) in anesthetized cats, and we calculated resistance of large and small cerebral vessels. Resistance of large arteries (> 200 μm diam) was ~ 45% of total cerebral vascular resistance under control conditions. Vasopressin (40 mU/kg iv) decreased resistance of large arteries by 22 ± 7%; increased pial artery pressure by 10 ± 2 mmHg when aortic pressure was maintained at control levels, and increased small vessel resistance by 27 ± 11%. This increase in small vessel resistance apparently was an autoregulatory response to the increase in pial pressure. Cerebral blood flow was not changed (38 ± 4 vs. 37 ± 3 ml · min-1 · 100 g-1). Intravenous infusion of angiotensin (2 μg · kg-1 · min-1) increased large artery resistance by 32 ± 6%, decreased pial artery pressure 6 ± 3 mmHg with aortic pressure maintained constant, and decreased cerebral blood flow by 12 ± 1%. Thus circulating vasopressin, at concentrations similar to those observed during hemorrhage, selectively dilates large cerebral arteries and increases microvascular pressure without changes in cerebral blood flow. In contrast to vasopressin, angiotensin selectively increases resistance of large cerebral arteries and decreases cerebral microvascular pressure. Thus vasopressin and angiotensin, at doses that have minimal effects on cerebral blood flow, may play an important role in regulation of cerebral microvascular pressure.

UR - http://www.scopus.com/inward/record.url?scp=0023687892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023687892&partnerID=8YFLogxK

M3 - Article

VL - 255

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 1

ER -